Your session is about to expire
← Back to Search
ITM + Bupivacaine QLB for Postoperative Pain (qlcsection Trial)
qlcsection Trial Summary
This trial compared two methods of pain control after cesarean surgery.
qlcsection Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowqlcsection Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.qlcsection Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the common medical conditions that ITM + Bupivacaine QLB is used to treat?
"ITM + Bupivacaine QLB is an effective medical intervention for permphigus, acute nonspecific tenosynovitis, and general anesthesia."
Does the age limit for this test extend past 75 years old?
"This particular clinical trial is only seeking patients that are 18 to 45 years of age. In contrast, there are 515 trials for seniors and 90 for minors."
Are there any other cases in which ITM + Bupivacaine QLB have been studied?
"There are currently 123 on-going clinical trials evaluating ITM + Bupivacaine QLB, with 20 of them being in Phase 3. The majority of these ITM + Bupivacaine QLB trials are based in Philadelphia, but there are a total of 169 locations running these clinical trials."
Might this medication be appropriate for me?
"This study is looking for around 60 participants who are postoperative and aged 18-45. To be eligible, candidates must also be experiencing pain."
How many individuals are being subjected to this treatment?
"Yes, you can find this information on clinicaltrials.gov. The study was first posted on September 5th, 2017 and is currently looking for 60 patients from 1 site."
Are there any remaining openings for people who want to participate in this research project?
"That is correct. The clinicaltrials.gov website has information indicating that this study is still recruiting patients. The trial was first posted on September 5th, 2017 and was updated on June 2nd, 2022. Currently, the study is looking for 60 patients at 1 location."
Are there any known dangers to ITM + Bupivacaine QLB?
"ITM + Bupivacaine QLB has received a safety score of 3 from our team at Power. This is because ITM + Bupivacaine QLB is a Phase 3 trial, meaning that while there is some data supporting efficacy, there are multiple rounds of data supporting safety."
Share this study with friends
Copy Link
Messenger